Myriad had used its patents to maintain a complete monopoly on BRCA testing in the United States. It had forced multiple labs that were offering BRCA testing to stop.
Myriad usaba sus patentes para mantener un monopolio completo sobre exámenes de BRCA en EE.UU. Forzó a que muchos laboratorios que los ofrecían, dejaran de hacerlo.